Log in to save to my catalogue

Targetable BRAF and RAF1 Alterations in Advanced Pediatric Cancers

Targetable BRAF and RAF1 Alterations in Advanced Pediatric Cancers

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7794197

Targetable BRAF and RAF1 Alterations in Advanced Pediatric Cancers

About this item

Full title

Targetable BRAF and RAF1 Alterations in Advanced Pediatric Cancers

Publisher

Hoboken, USA: John Wiley & Sons, Inc

Journal title

The oncologist (Dayton, Ohio), 2021-01, Vol.26 (1), p.e153-e163

Language

English

Formats

Publication information

Publisher

Hoboken, USA: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

RAF family protein kinases signal through the MAPK pathway to orchestrate cellular proliferation, survival, and transformation. Identifying BRAF alterations in pediatric cancers is critically important as therapeutic agents targeting BRAF or MEK may be incorporated into the clinical management of these patients. In this study, we performed comprehe...

Alternative Titles

Full title

Targetable BRAF and RAF1 Alterations in Advanced Pediatric Cancers

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7794197

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7794197

Other Identifiers

ISSN

1083-7159

E-ISSN

1549-490X

DOI

10.1002/ONCO.13519

How to access this item